Quinine should no longer be the drug of choice for treating severe malaria, according to an updated systematic review by Cochrane researchers. It is now evident that the antimalarial drug artesunate, which is derived from ...
Mar 16, 2011
not rated yet
0
(PhysOrg.com) -- A range of new clinical, functional, and neuroimaging tests developed by researchers at UCL make it possible to track the progression of Huntington’s disease long before noticeable symptoms ...
Dec 03, 2010
5 / 5 (1)
0
B vitamin supplements are safe, but do not reduce subsequent vascular events (stroke, heart attack, or vascular death) in patients who have had a recent stroke or ischaemic attack, despite a lowering of homocysteine levels. ...
Aug 03, 2010
not rated yet
0
The incidence of strokes in rural Tanzania is similar to that reported in developed countries, but rates in urban Tanzania are almost three times higher. These findings highlight the urgent need for community-level health ...
Jul 05, 2010
3 / 5 (1)
0
New findings indicate that the target of autoantibodies that are associated with limbic encephalitis is LGI1 - a protein involved in fine-tuning of neuronal synapses. The results suggest that testing for these antibodies ...
Jun 27, 2010
5 / 5 (1)
0
Pramipexole, a dopamine agonist, improves depressive symptoms in patients with Parkinson's disease (PD), and has the potential to become an important antidepressant treatment for these patients. The Article published Online ...
May 09, 2010
4 / 5 (2)
0
|
(AP) -- Lithium doesn't help patients with ALS, or Lou Gehrig's disease, contrary to previous study results, new research says.
Apr 06, 2010
5 / 5 (1)
1
Hypertension is the most prevalent treatable risk factor for stroke. One in two adults are affected by it, and the risk of being hypertensive during a lifetime is about 90%. Despite this, the underlying mechanisms by which ...
Mar 11, 2010
5 / 5 (2)
3
A neuroimaging technique known as ¹¹C-PiB PET* shows that a new investigational drug, bapineuzumab,** reduces amyloid-β deposits in the brain by about 25% compared with placebo in patients who have mild-to-moderate ...
Feb 28, 2010
not rated yet
0
An international team of researchers has found that adding a humanized monoclonal antibody called daclizumab to standard treatment reduces the number of new or enlarged brain lesions in patients with relapsing multiple sclerosis. ...
Feb 16, 2010
not rated yet
0
A substantial percentage of children who get CT scans after apparently minor head trauma do not need them, and as a result are put at increased risk of cancer due to radiation exposure. After analyzing more than 42,000 children ...
Sep 15, 2009
not rated yet
0
New research into the effects of antipsychotic drugs commonly prescribed to Alzheimer's patients concludes that the medication nearly doubles risk of death over three years. The study, funded by the Alzheimer's Research Trust, ...
Jan 09, 2009
5 / 5 (6)
6
